Saturday, November 7, 2026

Las Ramblas Streets Were Packed Full of People Honoring Lives Lost in Barcelona's Terror

Evan McCaffrey

August 18, 2017

Sorrow in Las Ramblas Memorial
[caption id="attachment_1974" align="aligncenter" width="640"]Woman holding sign against terrorism in Las Ramblas memorial. Photo by: Evan McCaffrey Woman holding a sign against terrorism in Las Ramblas memorial. Photo by: Evan McCaffrey[/caption] Today, in the same location where a terrorist's van killed 13 pedestrians, thousands of people marched in defiance against terrorism. Las Ramblas Streets were packed full of people chanting and waving banners and flags. [caption id="attachment_1975" align="aligncenter" width="640"]Las Ramblas memorial. Photo by: Evan McCaffrey Las Ramblas memorial. Photo by: Evan McCaffrey[/caption] Makeshift memorials were made in the spots where the dead had previously laid. Many of these spots were formed by family members of the deceased, who had laid down the individuals belongings with flowers and candles. By the end of the march, the memorials had grown with gifts from crowd members paying their respects. [caption id="attachment_1976" align="aligncenter" width="640"]Las Ramblas memorial. Photo by: Evan McCaffrey Las Ramblas memorial. Photo by: Evan McCaffrey[/caption] Amongst the gifts were stuffed animals and kids toys to remember the small children that had been killed. [caption id="attachment_1977" align="aligncenter" width="640"]Las Ramblas memorial. Photo by: Evan McCaffrey Las Ramblas memorial. Photo by: Evan McCaffrey[/caption] A somber mood could be felt all around, but we must remember that everyone that came out today took a risk during an ongoing terrorist incident. [caption id="attachment_1978" align="aligncenter" width="640"]Woman holding a sign with the hashtag "NotInMyName" in Las Ramblas memorial. Photo by: Evan McCaffrey Woman holding a sign with the hashtag "NotInMyName" in Las Ramblas memorial. Photo by: Evan McCaffrey[/caption] It was truly a defiant act.

Categories

Tags

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com